DUBLIN--(BUSINESS WIRE)--The "Monoclonal Antibodies Market - Forecasts from 2018 to 2023" report has been added to ResearchAndMarkets.com's offering.
The monoclonal antibodies market is projected to grow at a CAGR of 6.34% to reach US$131.766 billion by 2023, from US$91.122 billion in 2017.
The market for monoclonal antibodies is driven by persistent innovation in drug development and discovery, increasing incidences of chronic diseases, favorable regulatory policies, and high adoption rate of therapeutic antibodies in emerging economies.
Key Topics Covered
1. Introduction
2. Research Methodology
3. Executive Summary
4. Market Dynamics
5. Monoclonal Antibodies Market by Indication
6. Monoclonal Antibodies Market by Source
7. Monoclonal Antibodies Market by Application
8. Monoclonal Antibodies Market by End-User
9. Monoclonal Antibodies Market by Geography
10. Competitive Intelligence
11. Company Profiles
- Eli Lily and Company
- AbbVie, Inc.
- Novartis AG
- Bristol Myers Squibb
- F.Hoffmann-La Roche Ltd.
- Johnson & Johnson Services, Inc.
- Amgen Inc.
- Merck & Co. Inc.
- Abbott
- AstraZeneca PLC
For more information about this report visit https://www.researchandmarkets.com/research/bjwq2r/the_monoclonal?w=4
